| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 11 5419-5426, Copyright © 1995 by American Association of Immunologists
ARTICLES |
E Bonifacio, V Lampasona, S Genovese, M Ferrari and E Bosi
Department of Medicine I, San Raffaele Scientific Institute, University of Milan, Italy.
The majority of patients with insulin-dependent diabetes (IDDM) have Abs to 40- and/or 37-kDa tryptic fragments (37/40K-Abs) deriving from an unidentified islet cell membrane protein distinct from glutamate decarboxylase (GAD). Recently, autoantibodies against ICA512, which has identity with the protein tyrosine phosphatase-like protein IA2, were reported. In this study we have examined whether IA2/ICA512 is the Ag specificity of 37/40K-Abs, and one of the determinants of islet cell Abs (ICA) detected by immunofluorescence. Serum from 51 of 100 new onset IDDM patients immunoprecipitated 40- and/or 37-kDa insulinoma polypeptides, and 53 immunoprecipitated in vitro translated rIA2; 49 had both 37/40K-Abs and rIA2 Abs. There were strong correlations between the levels of Abs to rIA2 and both 40 kDa (r = 0.85, p < 0.0001) and 37 kDa (r = 0.70, p < 0.0001) insulinoma polypeptides. Trypsin treatment of immunoprecipitated rIA2 yielded 40- and 37-kDa fragments, and preincubation of sera with rIA2 completely inhibited binding to the insulinoma 40- and 37-kDa polypeptides. IA2 Ab levels also correlated with ICA titer in GAD-Ab negative sera, and preincubation with rIA2 reduced ICA staining intensity in sera with ICA and IA2 Abs, but not in sera with ICA in the absence of IA2 Abs. These results provide clear evidence for the identification of IA2/ICA512 as the precursor of the islet 40- and 37-kDa polypeptide autoantigens and as one of the ICA specificities. Combined detection of Abs to IA2 and GAD65 in a single radio-binding assay identified Abs in 88 of 100 IDDM patients, and potentially facilitates population screening for IDDM risk assessment.
This article has been cited by other articles:
|
|
 |
|
  C. Tiberti, C. Giordano, M. Locatelli, E. Bosi, G. F. Bottazzo, R. Buzzetti, D. Cucinotta, A. Galluzzo, A. Falorni, and F. Dotta Identification of Tyrosine Phosphatase 2(256-760) Construct as a New, Sensitive Marker for the Detection of Islet Autoimmunity in Type 2 Diabetic Patients: The Non-Insulin Requiring Autoimmune Diabetes (NIRAD) Study 2 Diabetes, May 1, 2008; 57(5): 1276 - 1283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Burton, E. Vincent, P. Y. Arnold, G. P. Lennon, M. Smeltzer, C.-S. Li, K. Haskins, J. Hutton, R. M. Tisch, E. E. Sercarz, et al. On the Pathogenicity of Autoantigen-Specific T-Cell Receptors Diabetes, May 1, 2008; 57(5): 1321 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Monti, M. Scirpoli, A. Rigamonti, A. Mayr, A. Jaeger, R. Bonfanti, G. Chiumello, A. G. Ziegler, and E. Bonifacio Evidence for In Vivo Primed and Expanded Autoreactive T Cells as a Specific Feature of Patients with Type 1 Diabetes J. Immunol., November 1, 2007; 179(9): 5785 - 5792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Wenzlau, K. Juhl, L. Yu, O. Moua, S. A. Sarkar, P. Gottlieb, M. Rewers, G. S. Eisenbarth, J. Jensen, H. W. Davidson, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes PNAS, October 23, 2007; 104(43): 17040 - 17045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Genovese, E Bazzigaluppi, D Goncalves, A Ciucci, M G Cavallo, F Purrello, M Anello, C M Rotella, G Bardini, O Vaccaro, et al. Clinical phenotype and {beta}-cell autoimmunity in Italian patients with adult-onset diabetes. Eur. J. Endocrinol., March 1, 2006; 154(3): 441 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Soderbergh, A. G. Myhre, O. Ekwall, G. Gebre-Medhin, H. Hedstrand, E. Landgren, A. Miettinen, P. Eskelin, M. Halonen, T. Tuomi, et al. Prevalence and Clinical Associations of 10 Defined Autoantibodies in Autoimmune Polyendocrine Syndrome Type I J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 557 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-R. Pastore, E. Bazzigaluppi, C. Belloni, C. Arcovio, E. Bonifacio, and E. Bosi Six Months of Gluten-Free Diet Do Not Influence Autoantibody Titers, but Improve Insulin Secretion in Subjects at High Risk for Type 1 Diabetes J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 162 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. E. Winter, N. Harris, and D. Schatz Immunological Markers in the Diagnosis and Prediction of Autoimmune Type 1a Diabetes Clin. Diabetes, October 1, 2002; 20(4): 183 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Christie, J. Molvig, C. J. Hawkes, B. Carstensen, T. Mandrup-Poulsen, and the Canadian-European Randomised Control Trial Gro IA-2 Antibody-Negative Status Predicts Remission and Recovery of C-Peptide Levels in Type 1 Diabetic Patients Treated With Cyclosporin Diabetes Care, July 1, 2002; 25(7): 1192 - 1197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bearzatto, H. Naserke, S. Piquer, K. Koczwara, V. Lampasona, A. Williams, M. R. Christie, P. J. Bingley, A.-G. Ziegler, and E. Bonifacio Two Distinctly HLA-Associated Contiguous Linear Epitopes Uniquely Expressed Within the Islet Antigen 2 Molecule Are Major Autoantibody Epitopes of the Diabetes-Specific Tyrosine Phosphatase-Like Protein Autoantigens J. Immunol., April 15, 2002; 168(8): 4202 - 4208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. LaGasse, M. S. Brantley, N. J. Leech, R. E. Rowe, S. Monks, J. P. Palmer, G. T. Nepom, D. K. McCulloch, and W. A. Hagopian Successful Prospective Prediction of Type 1 Diabetes in Schoolchildren Through Multiple Defined Autoantibodies: An 8-year follow-up of the Washington State Diabetes Prediction Study Diabetes Care, March 1, 2002; 25(3): 505 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Knip Can We Predict Type 1 Diabetes in the General Population? Diabetes Care, March 1, 2002; 25(3): 623 - 625. [Full Text] [PDF]
|
|
|
|
|
|
A. Kupila, P. Keskinen, T. Simell, S. Erkkila, P. Arvilommi, S. Korhonen, T. Kimpimaki, M. Sjoroos, M. Ronkainen, J. Ilonen, et al. Genetic Risk Determines the Emergence of Diabetes-Associated Autoantibodies in Young Children Diabetes, March 1, 2002; 51(3): 646 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bosi, S. Braghi, P. Maffi, M. Scirpoli, F. Bertuzzi, G. Pozza, A. Secchi, and E. Bonifacio Autoantibody Response to Islet Transplantation in Type 1 Diabetes Diabetes, November 1, 2001; 50(11): 2464 - 2471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Diez, Y. Park, M. Zeller, D. Brown, D. Garza, C. Ricordi, J. Hutton, G. S. Eisenbarth, and A. Pugliese Differential Splicing of the IA-2 mRNA in Pancreas and Lymphoid Organs as a Permissive Genetic Mechanism for Autoimmunity Against the IA-2 Type 1 Diabetes Autoantigen Diabetes, April 1, 2001; 50(4): 895 - 900. [Abstract] [Full Text]
|
|
|
|
|
|
S. Trembleau, G. Penna, S. Gregori, G. Magistrelli, A. Isacchi, and L. Adorini Early Th1 Response in Unprimed Nonobese Diabetic Mice to the Tyrosine Phosphatase-Like Insulinoma-Associated Protein 2, an Autoantigen in Type 1 Diabetes J. Immunol., December 15, 2000; 165(12): 6748 - 6755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Törn, M. Landin-Olsson, A. Lernmark, J. P. Palmer, H. J. Arnqvist, G. Blohmé, F. Lithner, B. Littorin, L. Nyström, B. Scherstén, et al. Prognostic Factors for the Course of {beta} Cell Function in Autoimmune Diabetes J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4619 - 4623. [Abstract] [Full Text]
|
|
|
|
|
|
A. Holz, T. Dyrberg, W. Hagopian, D. Homann, M. v. Herrath, and M. B. A. Oldstone Neither B Lymphocytes Nor Antibodies Directed Against Self Antigens of the Islets of Langerhans Are Required for Development of Virus-Induced Autoimmune Diabetes J. Immunol., November 15, 2000; 165(10): 5945 - 5953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Jubault, A. Penfornis, F. Schillo, B. Hoen, M. Izembart, J. Timsit, M. D. Kazatchkine, J. Gilquin, and J.-P. Viard Sequential Occurrence of Thyroid Autoantibodies and Graves' Disease after Immune Restoration in Severely Immunocompromised Human Immunodeficiency Virus-1-Infected Patients J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4254 - 4257. [Abstract] [Full Text]
|
|
|
|
|
|
E. Bonifacio, M. Scirpoli, K. Kredel, M. Fuchtenbusch, and A.-G. Ziegler Early Autoantibody Responses in Prediabetes Are IgG1 Dominated and Suggest Antigen-Specific Regulation J. Immunol., July 1, 1999; 163(1): 525 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. Naserke, A.-G. Ziegler, V. Lampasona, and E. Bonifacio Early Development and Spreading of Autoantibodies to Epitopes of IA-2 and Their Association with Progression to Type 1 Diabetes J. Immunol., December 15, 1998; 161(12): 6963 - 6969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bonifacio, V. Lampasona, and P. J. Bingley IA-2 (Islet Cell Antigen 512) Is the Primary Target of Humoral Autoimmunity Against Type 1 Diabetes-Associated Tyrosine Phosphatase Autoantigens J. Immunol., September 1, 1998; 161(5): 2648 - 2654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Hummel, I Durinovic-Bello, E Bonifacio, V Lampasona, J Endl, S Fessele, F T. Bergh, C Trenkwalder, E Standl, and A-G Ziegler Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus J. Neurol. Neurosurg. Psychiatry, August 1, 1998; 65(2): 204 - 208. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Borg, P. Fernlund, and G. Sundkvist Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus Clin. Chem., December 1, 1997; 43(12): 2358 - 2363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Borg, P. Fernlund, and G. Sundkvist Measurement of antibodies against glutamic acid decarboxylase 65 (GADA): two new 125I assays compared with [35S]GAD 65-ligand binding assay Clin. Chem., May 1, 1997; 43(5): 779 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kawasaki, L. Yu, R. Gianani, C. F. Verge, S. Babu, E. Bonifacio, and G. S. Eisenbarth Evaluation of Islet Cell Antigen (ICA) 512/IA-2 Autoantibody Radioassays Using Overlapping ICA512/IA-2 Constructs J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 375 - 380. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
